3E Bioventures Capital is a healthcare focused venture capital firm based in Beijing, China. The firm seeks to make investments in the drug, device, diagnostics, healthcare information technology and medical services sectors.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Cardea Bio | 12-Jan-2021 | Later Stage VC | 0000 | Other Healthcare Technology Systems | Generating Revenue | |
000000 000000 | 07-Jan-2021 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | |
000000 0000000 | 19-Nov-2020 | 00000 00000 | 000.00 | Other Healthcare Technology Systems | Generating Revenue | 000 000 |
00000 000000000 | 18-Nov-2020 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - General | 00000 000 00.0 |
0000000000 | 15-Sep-2020 | 00000 00000 | 00000 | Biotechnology | Generating Revenue | |
0000000000 | 09-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - Phase 3 | 00000 000 00.0 |
000 00000000000 | 26-Aug-2020 | 00000 00000 | 000.00 | Biotechnology | Profitable | |
00 000000000000 | 29-May-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | |
Purinomia Biotech | 07-May-2020 | Early Stage VC | 00.000 | Biotechnology | Generating Revenue | |
Chigene | 14-Apr-2020 | Later Stage VC | Decision/Risk Analysis | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
OncoImmune | 23-Nov-2020 | Merger/Acquisition | 00000 |
00 000000000000 | 02-Oct-2020 | 000 | 00000 |
000000 000000000 | 24-Sep-2020 | 000000000000000000 | |
000000000 | 29-Jul-2020 | 000 | 00000 |
00000 0000000000 | 31-Oct-2018 | 000 | 0000 |
0000000 00000000'0 | 22-Sep-2018 | 000000000000000000 | 000.00 |
00000000 000000000 | 06-Jul-2016 | 000000000000000000 | |
000000000 | 06-Jan-2016 | 000 | |
BGI Tech | 14-Jan-2015 | Merger of Equals | |
Chiral Quest | Secondary Transaction - Open Market |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Lue Sun | President | 0 | Beijing, China | ||
Karen Liu Ph.D | Founding Partner | 00 | 0 | 0 | Beijing, China |
Joy Yang Ph.D | Venture Partner | Beijing, China | |||
Francine Fang Ph.D | Partner | 0 | Beijing, China | ||
Hao Zhou | Partner | Beijing, China |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ShangBay Capital | 3 | 0 |
![]() |
![]() |
|
Tsingyuan Ventures | 0 | 0 |
![]() |
![]() |
|
Bay City Capital | 0 | 0 |
![]() |
![]() |
|
Cowin Capital | 0 |
![]() |
![]() |
||
Northern Light Venture Capital | 0 | 0 |
![]() |
![]() |